Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sherri Newmyer"'
Autor:
Marvin A. Ssemadaali, Juan Arredondo, Elise A. Buser, Sherri Newmyer, Harikrishnan Radhakrishnan, Harold S. Javitz, Satya Dandekar, Parijat Bhatnagar
Publikováno v:
Bioengineering & Translational Medicine, Vol 8, Iss 3, Pp n/a-n/a (2023)
Abstract We have developed a serology test platform for identifying individuals with prior exposure to specific viral infections and provide data to help reduce public health risks. The serology test composed of a pair of cell lines engineered to exp
Externí odkaz:
https://doaj.org/article/4df3d1b712484c9d87009d19de5fa068
Autor:
Sherri Newmyer, Marvin A. Ssemadaali, Harikrishnan Radhakrishnan, Harold S. Javitz, Parijat Bhatnagar
Publikováno v:
Bioengineering & Translational Medicine, Vol 8, Iss 2, Pp n/a-n/a (2023)
Abstract This work reports on an engineered cell that—when electrically stimulated—synthesizes a desired protein, that is, ES‐Biofactory. The platform has been used to express interferon (IFN)‐β as a universal antiviral protein. Compelling e
Externí odkaz:
https://doaj.org/article/0951b883684548f284a9c9c4201f53e1
Autor:
Marvin A. Ssemadaali, Sherri Newmyer, Harikrishnan Radhakrishnan, Juan Arredondo, Harold S. Javitz, Satya Dandekar, Parijat Bhatnagar
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 4 (2022)
ABSTRACT We have engineered a cell that can be used for diagnosing active severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Isolation of individuals with active infections offers an effective solution for mitigating pandemics.
Externí odkaz:
https://doaj.org/article/8ade061a6e2d49828df44af62328a99c
Autor:
Sherri Newmyer, Marvin A. Ssemadaali, Harikrishnan Radhakrishnan, Harold S. Javitz, Parijat Bhatnagar
Publikováno v:
Bioengineering & Translational Medicine. 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3b3be4c7d5880ce1716976fbe180c70
https://doi.org/10.1002/btm2.10434
https://doi.org/10.1002/btm2.10434
Autor:
Marvin A. Ssemadaali, Sherri Newmyer, Harikrishnan Radhakrishnan, Juan Arredondo, Harold S. Javitz, Satya Dandekar, Parijat Bhatnagar
1.0AbstractVaccines help reduce new infections, but interventions that can prevent the disease from transitioning to a severe stage are rather limited. Dysregulated IFN kinetics are mostly exploited by pathogenic viruses, including SARS-CoV-2. The cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49e38416534a91bb77612860c49ce815
https://doi.org/10.1101/2022.06.26.497669
https://doi.org/10.1101/2022.06.26.497669
Autor:
Harikrishnan Radhakrishnan, Sherri Newmyer, Claire E. Repellin, Parijat Bhatnagar, Marvin A Ssemadaali, Harold S. Javitz
Publikováno v:
Adv Biol (Weinh)
The NK-92MI, a fast-growing cytolytic cell line with a track record of exerting clinical efficacy, is transformed into a vector for synthesizing calibrated amounts of desired engineered proteins at our disease site, that is, NK-cell Biofactory. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50335d0851296c29f88b1cb1140badd6
https://europepmc.org/articles/PMC8275051/
https://europepmc.org/articles/PMC8275051/